Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2003 May;41(5):2247–2248. doi: 10.1128/JCM.41.5.2247-2248.2003

Bacteremia Due to Three Bacillus Species in a Case of Munchausen's Syndrome

Jason Galanos 1, Shalinie Perera 2, Haydn Smith 2, David O'Neal 1, Harsha Sheorey 2,*, Mary Jo Waters 2
PMCID: PMC154744  PMID: 12734293

Abstract

We report on a case of recurrent bacteremia due to three Bacillus spp. in an immunocompetent patient with no history of intravenous drug use. The source of the organisms was postulated to be a self-injected compound containing Bacillus spores, given the patient's past history of psychiatric illness and self-destructive behavior.

CASE REPORT

An 18-year-old female presented to our emergency department with a 6-h history of an acute onset of a retro-orbital headache, a nonproductive cough, and poorly localized abdominal pain. Three weeks earlier the patient had been briefly hospitalized at the same institution for an episode of enteroviral meningitis.

On examination, she was afebrile, had no signs of meningism, and had no focal neurology. Cardiorespiratory and abdominal examinations were normal. She was admitted to a hospital ward for further evaluation and observation.

Twelve hours later she became febrile (39°C), tachycardic (180 beats/min), and hypotensive (systolic blood pressure, 85 mm/Hg). Her white blood cell count and C-reactive protein (CRP) level rapidly became elevated, and the results of liver function tests became abnormal. A chest X ray was normal, and a computed tomography scan of her abdomen and pelvis revealed a small amount of free fluid in the pelvis, with a normal pancreas and liver. Because an abdominal focus was suspected, the patient was treated empirically with ampicillin, gentamicin, and metronidazole. Six sets of cultures of blood collected at this stage grew three Bacillus species that were identified as Bacillus licheniformis, Bacillus pumilus, and Paenibacillus polymyxa (formerly Bacillus polymyxa). Once these blood culture results were known, the antibiotic regimen was changed to vancomycin, ciprofloxacin, and metronidazole.

After the commencement of intravenous antibiotic treatment, the patient rapidly became afebrile, followed by normalization of her inflammatory markers over the ensuing 72 h. However, she continued to complain of epigastric pain and exhibited mild epigastric tenderness but had no clinical evidence of peritonitis. A gastroscopy performed at this stage revealed no abnormality. Three further sets of cultures of blood collected after 9 days of treatment were negative. After 15 days of treatment, vancomycin was withdrawn, and ciprofloxacin and metronidazole were continued. On the day that vancomycin treatment was ceased, the patient again became febrile, with hypotension, tachycardia, and an elevation in CRP levels and the white blood cell count. Blood cultures performed at this time once again grew B. pumilus. Vancomycin was reintroduced.

Following her second febrile episode, the patient was queried about potential self-induced medical illness (Munchausen's syndrome). She angrily denied any past psychiatric history and repeatedly threatened discharge against medical advice. At this stage, her parents reported finding some blood-stained bandages and syringes in her room at home. No illegal recreational drug substances were found. However, for ethical reasons a search of her hospital room was not performed without her consent.

An extensive previous psychiatric history, which was subsequently obtained from her psychiatrist, included previous self-destructive behavior, with at least one episode of self-injection of soil. She also had a history of a 6-month inpatient stay in a psychiatric institution at the age of 16 for an eating disorder. There was, however, no documented history of illicit drug use.

On becoming afebrile, vancomycin was withdrawn and she was continued on oral ciprofloxacin and metronidazole. Remaining well, she was discharged to the care of her psychiatric team, who were also of the opinion that her presentation was consistent with a diagnosis of Munchausen's syndrome and the product of severe psychopathology.

Blood cultures were processed in BACTEC PLUS Aerobic/F and Anaerobic/F systems (Becton Dickinson Diagnostic Instrument Systems, Sparks, Md.). Three Bacillus species (Table 1) were isolated from all six sets of cultures of blood collected on admission. Three further sets of cultures of blood collected on day 9 were negative, while the patient was still receiving antibiotics. B. pumilus was reisolated from one set after vancomycin was withdrawn on day 15. The three Bacillus spp. were identified on the basis of the results of the tests given in Table 1.

TABLE 1.

Biochemical reactions of the Bacillus spp.a

Test B. licheniformis B. pumilus P. polymyxa
Gram stain GPR, central spores nondistending cell GPR, paracentral spores nondistending cell GPR, sub terminal spore, nondistending cell
Motility + + +
Hemolysis + + +
Anaerobic growth + + (weak) + (weak)
Pigment Green
Catalase + + +
Casein hydrolysis + + + (weak)
Arginine dyhydrolase +
Indole
Lecithinase
Nitrate reduction + +
Starch hydrolysis + +
Acid from:
    Arabinose + + +
    Glycerol + +
    Salicin + + +
    Trehalose + + +
    Mannitol + + +
a

GPR, gram-positive rod; +, positive; −, negative.

Sensitivity testing was done on the isolates by the disk diffusion method. The NCCLS interpretive standards established for staphylococci were used since no interpretive standards have been established for Bacillus spp. (4, 5). All three species were sensitive to cefazolin, vancomycin, chloramphenicol, tobramycin, gentamicin, ciprofloxacin, and clindamycin. B. pumilus was sensitive to penicillin, while B. licheniformis and P. polymyxa were resistant.

Bacillus spp. are aerobic gram-positive, spore-bearing rods usually found in decaying organic matter, dust, soil, and water; and some are part of the human gut and skin flora (8).

Since Bacillus spp. are common laboratory contaminants, isolation of the organisms in cultures of blood does not indicate infection unless they are detected in multiple sets. Our patient was considered to have true bacteremia, as the Bacillus spp. grew from multiple sets of blood culture bottles.

Several reports of bacteremia due to Bacillus spp., mostly in immunocompromised patients, have been published in the literature (2, 6).

In immunocompetent individuals, B. licheniformis bacteremia has been reported in association with central venous catheters (1) and in a patient with prosthetic valve endocarditis (7). A case of B. licheniformis bacteremia following self-inoculation of an organic drain cleaner (a product that includes spores of B. licheniformis, B. pumilus, and other Bacillus spp.) has also been reported (3). B. pumilus bacteremia has been reported only in immunocompromised patients (2).

It is likely that our patient injected herself twice with a substance containing the organisms. The source of the organisms, although not found, is likely to be a compound containing Bacillus spores. Septic tank products contain spores of B. licheniformis, B. polymixa, B. subtilis, and other Bacillus spp. Even though two episodes of significant bacteremia due to three Bacillus spp. in an otherwise immunocompetent host in the absence of a history of intravenous drug use did suggest the possibility of Munchausen's syndrome, impediments to obtaining her past psychiatric history delayed the diagnosis. Had the diagnosis been reached earlier, a second episode of septicemia may have been avoided.

The repeated isolation of an uncommon pathogen in blood suggests an unusual source and warrants a detailed history.

Acknowledgments

We thank the Microbiological Diagnostic Unit, University of Melbourne, for identification of the organisms.

REFERENCES

  • 1.Blue, S. R., V. R. Singh, and M. A. Sanbolle. 1995. Bacillus licheniformis bacteraemia: five cases associated with indwelling central venous catheters. Clin. Infect. Dis. 20:629-633. [DOI] [PubMed] [Google Scholar]
  • 2.Cotton, D. J., V. J. Gill, D. J. Marshal, J. Gress, M. Thaler, and P. A. Pizzo. 1987. Clinical features and therapeutic intervention in 17 cases of Bacillus bacteraemia in an immunosuppressed patient population. J. Clin. Microbiol. 25:672-674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hannah, W., Jr., and P. T. Ender. 1999. Persistent Bacillus licheniformis bacteraemia associated with an intentional injection of organic drain cleaner. Clin. Infect. Dis. 29:659-661. [DOI] [PubMed] [Google Scholar]
  • 4.National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial disk susceptibility tests, 7th ed. Approved standard M2-A7. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  • 5.National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing. 11th informational supplement. M100-S11. National Committee for Clinical Laboratory Standards, Wayne Pa.
  • 6.Oggioni, M. R., G. Pozzi, P. E. Valensin, P. Galieni, and C. Bigazzi. 1998. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J. Clin. Microbiol. 36:325-326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Santini, F., V. Borghetti, G. Amalfitano, and A. Mazzucco. 1995. Bacillus licheniformis prosthetic valve endocarditis. J. Clin. Microbiol. 33:3070-3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tuazon, C. U. 2000. Other Bacillus species, p. 2220-2226. In G. L. Mandell, J. E. Bennette, and R. Dolin (ed.), Mandel, Douglas and Bennette's principles and practice of infectious diseases, 5th ed. Churchill Livingston, Philadelphia, Pa.

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES